Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board

09 October 2019

We propose the establishment of a new Developing Antibiotics for Resistant Targets (DART) Board to improve the targeting of incentives for antibiotic development. The DART Board would comprise clinical experts, patient advocates, and representatives from government, industry, and nonprofit organizations.

Further reading: Annals of Internal Medicine

Author(s): Brad Spellberg, MD; Travis B. Nielsen, PhD; David N. Gilbert, MD; Andrew F. Shorr, MD, MPH, MBA; Eric P. Brass, MD, PhD

Smart Innovations